New South Wales, Australia

Philip John Bell

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Microbiogen Pty. Ltd.. Active years: 2014.



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Philip John Bell

Introduction

Philip John Bell is an accomplished inventor based in New South Wales, Australia. He has made significant contributions to the field of microbiology, particularly in the development of strains capable of utilizing xylose as a sole carbon source. His innovative work has implications for various applications, including biofuels and bioprocessing.

Latest Patents

Philip John Bell holds 1 patent related to methods for producing strains that can grow on xylose at a desired growth rate. This patent focuses on strains that can achieve at least one generation per 48 hours using xylose as their sole carbon source, developed through non-recombinant methods. This advancement is crucial for enhancing the efficiency of microbial processes.

Career Highlights

Throughout his career, Philip has been associated with Microbiogen Pty. Ltd., where he has played a pivotal role in research and development. His expertise in microbiology and fermentation technology has contributed to the company's innovative projects and initiatives.

Collaborations

Philip John Bell has collaborated with notable professionals in his field, including his coworker Paul Victor Attfield. Their combined efforts have led to advancements in microbial strain development and applications in various industries.

Conclusion

Philip John Bell's contributions to the field of microbiology and his innovative patent demonstrate his commitment to advancing scientific knowledge and practical applications. His work continues to influence the development of efficient microbial processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…